WellPoint Will Cover Merck's GardasilJuly 3, 2006 Health insurance company WellPoint Inc. said Thursday it will cover Merck & Co.'s vaccine that blocks the two types of the STD human papillomavirus (HPV) responsible for about 70 percent of cervical cancers. Earlier on Thursday, CDC's Advisory Committee on Immunization Practices recommended the Gardasil vaccine be routinely given to girls ages 11-12. Health officials estimated that more than half of sexually active women and men will be infected with one or more types of HPV in their lifetime. WellPoint said its decision to cover Gardasil was prompted by the committee's recommendation. Back to other news for July 3, 2006 Associated Press 06.29.06 This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |